CorVel (NASDAQ:CRVL) Director R Judd Jessup Sells 1,562 Shares

CorVel Corp. (NASDAQ:CRVL) Director R Judd Jessup sold 1,562 shares of the business’s stock in a transaction dated Wednesday, August 26th. The stock was sold at an average price of $70.71, for a total value of $110,449.02. Following the transaction, the director directly owned 117,083 shares of the company’s stock, valued at approximately $8,278,938.93. The trade was a 1.32% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.

R Judd Jessup also recently made the following trade(s):

• On Thursday, August 27th, R Judd Jessup sold 1,262 shares of CorVel stock. The shares were sold at an average price of $70.64, for a total transaction of $89,147.68.

CorVel Trading Down 0.3%

CRVL opened at $69.24 on Friday. The company has a market cap of $3.53 billion, a P/E ratio of 30.77 and a beta of 0.98. The company’s 50 day moving average is $63.41 and its 200-day moving average is $58.22. CorVel Corp. has a 1-year low of $44.83 and a 1-year high of $93.45.

CorVel (NASDAQ:CRVL) last issued its earnings results on Tuesday, August 4th. The business services provider reported $0.63 earnings per share for the quarter. The firm had revenue of $259.93 million for the quarter. CorVel had a net margin of 11.72% and a return on equity of 29.92%.

Hedge Funds Weigh In On CorVel

A number of hedge funds and other institutional investors have recently made changes to their positions in CRVL. Walleye Capital LLC acquired a new stake in CorVel during the 2nd quarter valued at approximately $3,308,000. NewEdge Wealth LLC acquired a new position in shares of CorVel in the 2nd quarter worth approximately $1,956,000. BlackRock Inc. acquired a new position in shares of CorVel in the 2nd quarter worth approximately $321,316,000. OneDigital Investment Advisors LLC bought a new stake in shares of CorVel in the 2nd quarter valued at $1,101,000. Finally, Deutsche Bank AG bought a new stake in shares of CorVel in the 2nd quarter valued at $3,772,000. 51.36% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts recently issued reports on CRVL shares. Wall Street Zen upgraded shares of CorVel from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Weiss Ratings raised shares of CorVel from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 16th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, CorVel has a consensus rating of “Hold”.

About CorVel

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).